Afferent Pharmaceuticals
First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting P2X3 receptors.
Get a Demo and See the Full Profile
Get a demo today to see profiles of Afferent Pharmaceuticals plus 5906 other startups.
